Intermittent fasting- the future treatment in nash patients?
Sign Up to like & getrecommendations! Published in 2023 at "Hepatology"
DOI: 10.1097/hep.0000000000000330
Abstract: Non-alcoholic steatohepatitis (NASH) is one of the leading causes of chronic liver disease with the potential of evolving towards end-stage liver disease and hepatocellular carcinoma (HCC), even in the absence of cirrhosis. Apart from becoming… read more here.
Keywords: future treatment; fasting future; patients intermittent; intermittent fasting ... See more keywords
Risk factors for histological progression of nonalcoholic steatohepatitis analyzed from repeated biopsy cases.
Sign Up to like & getrecommendations! Published in 2020 at "Journal of gastroenterology and hepatology"
DOI: 10.1111/jgh.14968
Abstract: BACKGROUND AND AIM The most important prognostic factor for non-alcoholic steatohepatitis (NASH) is liver fibrosis. The aim of this study is to examine clinical parameters involved in pathological progression in NASH patients who underwent repeated… read more here.
Keywords: nash patients; risk factors; histological progression; steatohepatitis ... See more keywords
A Noninvasive Score Model for Prediction of NASH in Patients with Chronic Hepatitis B and Nonalcoholic Fatty Liver Disease
Sign Up to like & getrecommendations! Published in 2017 at "BioMed Research International"
DOI: 10.1155/2017/8793278
Abstract: Aims. To develop a noninvasive score model to predict NASH in patients with combined CHB and NAFLD. Objective and Methods. 65 CHB patients with NAFLD were divided into NASH group (34 patients) and non-NASH group… read more here.
Keywords: nash patients; noninvasive score; prediction nash; model ... See more keywords
E. coli NF73-1 Isolated From NASH Patients Aggravates NAFLD in Mice by Translocating Into the Liver and Stimulating M1 Polarization
Sign Up to like & getrecommendations! Published in 2020 at "Frontiers in Cellular and Infection Microbiology"
DOI: 10.3389/fcimb.2020.535940
Abstract: Objective The gut microbiota is associated with nonalcoholic fatty liver disease (NAFLD). We isolated the Escherichia coli strain NF73-1 from the intestines of a NASH patient and then investigated its effect and underlying mechanism. Methods… read more here.
Keywords: nf73 isolated; nash patients; nafld patients; nafld mice ... See more keywords
SPP1 and CXCL9 Promote Non-alcoholic Steatohepatitis Progression Based on Bioinformatics Analysis and Experimental Studies
Sign Up to like & getrecommendations! Published in 2022 at "Frontiers in Medicine"
DOI: 10.3389/fmed.2022.862278
Abstract: Background and Aims Non-alcoholic fatty liver disease (NAFLD) is a major chronic liver disease worldwide, and non-alcoholic steatohepatitis (NASH) is one of its pathological subtypes. The pathogenesis of NASH has not yet been fully elucidated.… read more here.
Keywords: spp1 cxcl9; non alcoholic; alcoholic steatohepatitis; healthy controls ... See more keywords
Hepatic Pin1 Expression, Particularly in Nuclei, Is Increased in NASH Patients in Accordance with Evidence of the Role of Pin1 in Lipid Accumulation Shown in Hepatoma Cell Lines
Sign Up to like & getrecommendations! Published in 2023 at "International Journal of Molecular Sciences"
DOI: 10.3390/ijms24108847
Abstract: Our previous studies using rodent models have suggested an essential role for Pin1 in the pathogenesis of non-alcoholic steatohepatitis (NASH). In addition, interestingly, serum Pin1 elevation has been reported in NASH patients. However, no studies… read more here.
Keywords: pin1 expression; pin1; lipid accumulation; expression ... See more keywords